Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal.Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in financing….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
